Post on 21-Jan-2018
Anatomy & physiology of thyroid gland
SURJEET ACHARYA
Thyroid gland -anatomy
Size : Lobes :5cm x 2.5cm x 2.5cmIsthmus: 1.2cm x 1.2 cm
Weight: 25g
Capsules of thyroid gland
True fibrous capsule
False fascial capsule
Suspensory ligament of Berry
On deglutation
Thyroid to hyoid –thyrohyoidThyroid to cricoid –cricothyroid
When mylohyoid contracts – hyoid pulled up
Parts & relations
• An Apex
• A Base
• 3 Surfaces : Lateral, Medial, Posterolateral
• 2 Borders : Anterior and Posterior
Arterial supply
Thyroid imaartery
Venous drainage
Tubercle of zuckerkandl
Nerve supply
Lymphatics
Histology
Large no of closed follicles
- Filled wit colloids- Lined by cuboidal
cells- Major constituents
– thyroglobulins Blood flow 5times
the weight
Physiology of thyroid gland
• Formation and Secretion of thyroid hormones –T3 & T4
• Metabolic Functions
• Regulation of their hormones
Steps in synthesis
• Iodide trapping
• Oxidation of Iodide ion
• Organification of thyroglobulin
• Coupling of Iodotyrosine residues
• Release of T3 & T4 into blood
Daily rate of secretion of hormones
• Thyroxine – 93%
• Triiodothyronine – 7%
• 1/4th of T4 deiodinated to additional T3
• Hormones delivered & used by tissues as T3
Transport of T3 & T4
• Bound to plasma proteins – TBG, TBPA & albumin
• Released slowly to tissue cells because of high affinity to plasma proteins ( T4 – 6 days, T3 – 1 day)
• Binds with intracellular proteins, stored in target cells, released slowly over periods
• Slow onset & long duration of action
Metabolism and excretion
• Intracellular thyroid hormone receptors high affinity to T3
• Before acting on target cells, deiodinase (D1&D2) enzymes remove one iodide from most of T4
• D3 responsible for inactivating T3 and preventing activation of T4 by converting it into RT3
• After inactivation, T3 conjugated with sulfates & glucuronides, excreted in bile, partially reabsorbed after deglucuronidation in intestines
• Effect on cellular metabolic activity
- Increases number & activity of mitochondria
- Increases active transport of ions through cell membranes
• Effect on other endocrine glands
- Controls rate of secretions of other glands
• Effect on sexual function
- Promotes normal functioning
Functions of TSH Increased proteolysis
of Tg Increased activity of
iodide pump Increased iodination
of tyrosine Increased size &
secretory activity of thyrois cells
Increased number of thyroid cells
THYROTOXICOSIS
THYROTOXICOSIS& HYPERTHYROIDISM
• Thyrotoxicosis- Symptom complex due to raised levels of thyroid hormones
• Hyperthyroidism- Thyrotoxicosis due to overproduction of thyroid hormones by the thyroid gland
• Hyperthyroidism is one of the causes of thyrotoxicosis
• Thyrotoxicosis can occur due to causes other than hyperthyroidism
HYRERTHYROIDISM
• Primary thyrotoxicosis – Graves disease, exophthalmic goitre, diffuse goitre (Basedow’sdisease)
• Secondary thyrotoxicosis – Secondary to multinodular goitre (Plummer disease)
• Tertiary thyrotoxicosis – Solitary toxic nodule –Autonomous nodule not under control of TSH but due to hypertrophy and hyperplasia of the gland (Goetsch’s disease)
RARE CAUSES
• Thyrotoxicosis factitia – drug induced- L thyroxine• Jod Basedow thyrotoxicosis – because of large doses of
iodides given to a hyperplastic endemic goiter• Autoimmune thyroiditis or de Quervain’s thyroiditis• Neonatal thyrotoxicosis• Struma ovarii• Drugs like amiodarone- an antiarrhythmic agent. Amiodarone
is rich in iodine having structural similarity to T4 causing thyrotoxicosis
• Well differentiated carcinoma can cause thyrotoxicosis-metastatic type
• Hydatidiform mole or choriocarcinoma with high levels of ß HCG can stimulate TSH receptor- thyrotoxicosis
GRAVES DISEASE
• Most common cause of hyperthyroidism
• Named after Irish physician Robert Graves
• Also referred as Basedow’s disease after Karl von Basedow who also described cases
• Autoimmune disease with TSH receptor antibodies in blood
`
• TSI/TsAb and LATS cause pathological changes in thyroid
• Histologically acinar cell hypertrophy and hyperplasia with absence of normal colloid in the tall columnar epithelium
• Familial
• Puberty, pregnancy, emotion and infection –precipitating factors
TOXIC ADENOMA
• Benign functioning monoclonal thyroid tumour
• Solitary nodule of thyroid
• Autonomous functioning tumour; not TSH responding
• Secretes large quantity of thyroid hormones suppressing the function of remaining normal thyroid tissue
• No eye signs and other features of Graves disease
• Higher T3 levels than T4
• TSH receptor or G protein- somatic mutation
• USG, T3,T4, TSH, Radioisotope scan (hot nodule)
T3 TOXICOSIS
• T3 alone is raised
• TSH decreased
• T4 normal
• Free T3 estimation is important
SUBCLINICAL HYPERTHYROIDISM
• Decreased TSH level but not undetectable with T3, T4, free T3, free T4 are within the normal range without any clinical symptoms
• Its incidence is 1% of hyperthyroidism
• Cause of infertility in females
• May present as cardiomyopathy or arrhythmias
• Hormone assay, radioisotope scan and US neck, ECG
STRUMA OVARII
• Ovarian teratoma with thyroid differentiation will secrete T3, T4 and suppress TSH
• Function of normal thyroid in neck is suppressed
• Radioisotope scan shows uptake in pelvis with no or less uptake in neck
HASHITOXICOSIS
• Due to autoimmune Hashimoto’s thyroiditis
• Mild toxic features develop during initial stage of hyperplasia
• Already formed thyroid hormones are released by inflamed gland causing toxicity
HYPERTHYROID EUTHYROID HYPOTHYROID
THYROTOXICOSIS FACTITIA
• Intake of L thyroxine without indications to lose weight
or
• Overdose intake of L thyroxine
Causing toxicity
Postpartum hyperthyroidism
• Exacerbation of previously confirmed or undiagnosed hyperthyroidism during pregnancy due to increased autoimmune factors
• It is associated with HLA DR3 and HLA DR5
NEONATAL THYROTOXICOSIS
• In infants born to mother with Graves disease due to crossing of the thyroid stimulating antibody across placental barrier
• Infant will be toxic for 3-4 weeks which subsides gradually
TROPHOBLASTIC THYROTOXICOSIS
• HCG secreted from vesicular mole, choriocarcinoma or metastatic embryonalcarcinoma in females, acts like TSAb causing toxicity
Jod basedow thyrotoxicosis
• Patient with hyperplastic endemic goitre takes large doses of iodine, taken up by hyperplastic gland in large quantity causing temporary hyperthyroidism
• It differs from Basedow disease (Graves disease)
Apathetic hyperthyroidism
• Lacks all usual clinical features of toxicity
• Old people
• Thyroid gland is not enlarged
• Behavioral problems
• Recent angina or atrial fibrillation
• Diagnosis is masked
Subacute thyroiditis
• A destructive release of preformed thyroid hormone
• Radioactive iodine uptake in the thyrotoxicphase of the disease
• Thyroid hormone levels can be highly elevated
• Low ESR, low T3 T4 ratio
Clinical Features of Thyrotoxicosis
HISTORY ?
BEFORE SUBJECT PROPER….
• An 11-year-old female with no significant past medical history presented with symptoms like weight loss and heat intolerance.
• She has also experienced a decline in grades at school.
• Family history is significant for thyroid disease in both grandmothers (both on thyroid replacement therapies).
• The clinician ordered thyroid function tests ; – Free T4, T3, TSH, anti-TSH receptor antibodies,
antithyroglobulin and antithyroid peroxidase antibodies.
• The results for the tests follow:– Free thyroxine (FT4)2.87 ng/dL (Increased)
– Triiodothyronine pediatric (T3)374.00 ng/dL(Increased)
– Thyroid-stimulating hormone (TSH) <0.018 uU/ml (Decreased)
– Thyroxine (T4)18.2 ug/dL (Increased)
– Antithyroglobulin antibodies >3000 IU/ml (positive)
– Antithyroid peroxidase antibodies2667 IU/mL (Positive)
– Anti-TSH receptor antibodies 69.6 % (Increased)
Diagnosis
Graves's disease
(hyperthyroidism with thyrotoxicosis)
* http://path.upmc.edu/cases/case537.html
Contributed by Anca V. Florea, MD and Mohamed A. Virji, MD, PhD
Objectives
• To elaborate on Clinical features in a patients with THYROTOXICOSIS.
– Symptoms
– Signs
• Eye signs
• Cardiac Manifestations
• Myopathy
• Pretibial Myxoedema
• Thyroid acropathy
• Other features
Symptoms
Goitre
Primary Thyrotoxicosis
• Diffuse
• Vascular
• Large or small
• Firm or soft
• Thrill/ Bruit
Secondary Thyrotoxicosis
• Nodular
• Insidious
Gastrointestinal System
Cardiovascular System
Genitourinary system
Skeletal system
Neuromuscular System
Integument
Psychiatry
Sympathetic Overactivity
Signs
Eye Signs
• Lid Retraction
• Von Graefe’s sign (Lid Lag)
• Stellwag’s sign
Exopthalmos
• Corneal ulceration
Malignant Exophthalmos
Grading Of Exophthalmos
• MildWidening of Palpebral fissure due to lid retraction
• Moderate Orbital deposition of fat causing bulging with positive Joffroy’s sign
• Severe Congestion with intraorbital oedema, raised intraocular pressure,diplopia and ophthalmoplegia
• Progressive Inspite of proper treatment progression of eye signs is seen with chemosis, corneal ulceration and ophthalmoplegia.
Pulse Rate
• Tachycardia (Crile’s grading)
• Sleeping PR – Three consecutive nights-Average.
• Grading of PR
– Grade I <90/min
– Grade II 90-110/min
– Grade III >110/min
Other CVS manifestaions
• Atrial Fibrillation
• Atrial flutter
• Extrasystole tachycardia
• Wide pulse pressure
Myopathy
• Weakness of proximal muscles (Thigh and arm muscles)Basedow Myopathy
• Weakness more during isometric contraction(getting down steps, lifting a bucket)
• Severe( resembles Myaesthenia gravis)
Pretibial Myxoedema
• Primary Thyrotoxicosis• Bilateral, symmetrical,shiny, red thickened dry skin with
coarse hair in the feet and ankles.• Severe skin of leg also get involved.• Due to deposition of Myxomatous tissue in skin and
subcutaneous plane.• Associated with exophthalmos with high levels of thyroid
stimulating antibodies.• Skin cyanotic on cold exposure.• Thyroid dermopathy
– Pretibial myxoedema, pruritus, palmar erythema, Hair thinning, Dupytren’s contracture.
Thyroid acropachy
• Clubbing of fingers and toes
• Primary thyrotoxicosis
• Hypertrophic pulmonary Osteoarthropathy.
Others
• Thrill in the upper pole of thyroid and Bruit on auscultation.
• Hepatosplenomegaly
INVESTIGATIONS
P
H
T
TRH
TSH
T3 AND T4
----
*TSH- Thyroid stimulating hormone ( 0-5IU/ml).
*T3 f- (3-9nmol/l).
*T4 f-(8-26nmol/l).
*RA I 123.
*TRH stimulation test- obsolete nowadays.
*Serum cholesterol.
*BMR- basal metabolic rate.
*Thyroid auto antibodies.
*Werner’s T3 suppression test .
*Thyroglobulin estimation study.( 0.5-50micg/l)
* FNAC of thyroid.
PRIMARY HYPERTHYROIDISM-INTRINSIC
• Etiology-
• Grave’s disease(most common)
• Intake of iodine supplements
• Inflammation (viral, certain medications and pregnancy)
• Carcinoma of the thyroid
• Toxic adenoma.
• TSH-
• HIGH RADIO ACTIVE IODINE UPTAKE.
• T4 TEST-
• USG SCAN
• Thyroid antibodies test- Thyroid peroxidaseantibody.
-Thyroglobulinantibody.
RA Iodine123
• Cold nodule or hot nodule.
• Done in MNG
• Solitary thyroid nodule
• Retrosternal goiter
• Graves disease
• struma ovary
Follicular carcinoma to rule out secondaries
• Contra indication- Pregnancy and lactation.
SECONDARY HYPERTHYROIDISM-EXTRINSIC
• Etiology-
• Thyroid stimulating hormone secreting pituitary adenoma
• Gestational thyrotoxicosis
• HCG producing tumor.
• TSH-
• T3 AND T4-
• TRH-
• USG of the thyroid
• CT scan of the head or MRI of brain to detect tumors in the pituitary gland.
T3 TOXICOSIS
• It is observed in some cases of toxic nodular goiter and most importantly with a solitary hyperfunctioning nodule.
• This should be suspected T4 I normal and absence of thyroxine binding globulin.
• Do a t3 suppression test.
• Serum cholesterol increased in hypothyroidism
• BMR increased in hyperthyroidism
• Thyroid antibodies- primary thyrotoxicosis
• Thyroglobulin estimation- used during follow up period especially in follicular carcinoma.
• Post thyroidectomy its level decreases.
• Follow up marker in well differentiated thyroid carcinoma.
• Sudden raise occurs in thyroiditis , primary or secondary toxic goiter.
FNAC
• To investigate the pathology.
• Used in the diagnosis of papillary ,medullary , anaplastic carcinomas, cold nodules , thyroiditis.
• 23G needle is used . Minimum 6 aspiration is done.
• Done in suspicious solitary/multiple nodule /dominant nodules.
• Mostly done under ultra sound guidance.
USG
• Identifies nodules, number , size ,vascularity ,echogenicity .
• For USG guided FNAC.
• To identify neck lymph nodes
• To identify solid or cystic lesions
• Benign lesion is hyperechoic , often cystic with well differentiated margins, shows egg shell calcifications as a rim .
• Malignant lesions is hypoechoic with poor margins with high vascularity, without any perfect halo.
TRH STIMULATION TEST
• It’s a test for hypothalamic –pituitary axis .• IV TRH- 200micg- RISE in TSH in 20 minutes
and reaches to normal in 20 minutes.• In pituitary insufficiency – TH deficiency – SUB
NORMAL responseIn hypothyroidism –
elevated TSH.
• This test is useful in doubtful hyperthyroidism,hypothyroidism,t3 toxicosisand in ophthalmic graves disease.
Thyrotoxicosis Management
Medical
Radioactive Iodine
Surgical
Anti-Thyroid Drugs
Carbimazole
Propylthiouracil
Propranolol
Nadalol
Indications:
• Toxicity in pregnant women
• Toxicity in children and young
adults
• Before thyroidectomy
• Soon after starting radioactive I therapy 131
Action:
Carbimazole- acts by blocking thyroid hormone
synthesis and suppresses autoimmune process in
thyroid in grave’s disease.
Propylthiouracil- blocks thyroid hormone synthesis and
blocks peripheral conversion of T4 to T3.
Dose:
Carbimazole- 10mg x 3 or 4 times/ day,
latent interval- 7 to 14 days and maintenance
dose- 5mg x 2 or 3 times/day for 6-24 months
Propylthiouracil- 200mg 8th hourly
Alternative:
Initial high dose of Carbimazole followed by
maintenance dose of 0.1-0.15mg thyroxine daily
Side effects:
Fever
Rash
Neuritis
Agranulocytosis
Lymph node
enlargement
Arthralgia
Myalgia
Psychosis
Liver cell
dysfunction
Hepatotoxicity
Propranolol:
dose:40mg tid
Action:
reduces cardiac problems
blocks peripheral conversion of T4 to T3
Contraindications:
bronchial asthma
heart block
cardiac failure
Advantages:
No surgery
No use of radioactive substances
Disadvantages:
Prolonged treatment
Failure rate-50%
ContraindicatedLarge gland size
Severity of disease
TSH-RAb levels
Surgery
Total Thyroidectomy
Hemi Thyroidectomy
Subtotal Thyroidectomy
Indications:
• Failure of drug treatment
• Autonomous toxic nodule
• Nodular toxic goitre
• Malignancy can’t be ruled out
• Graves in children, or with nodules
• Need for antithyroid drugs >2 years
• Large goitre, substernal/ intrathoracic goitre
• Pressure symptoms, Graves ophthalmopathy
• Amiodarone-induced thyrotoxicosis
Lugol’s iodine:
decreases vascularity of the gland & makes
more firm and easier to handle during surgery
Dose: 10-30drops/day for 10 days
prevents the release of hormone from the gland-
Thyroid Constipation
After 2 weeks effect - lost causing thyroid escape
from iodine control
Advantages:
o Rapid and high cure rate
o Radioiodine therapy avoided
o Tissue for biopsy, removes occult malignant foci
o Best option for ophthalmopathy
o Women planning for a child
o Coexisting parathyroid carcinoma- removed
o For intrathoracic retrosternal toxic thyroid
Disadvantages:
Recurrent thyrotoxicosis
Thyroid insufficiency
Complications of surgery itself
Hypothyroidism
RADIOACTIVE IODINE
Destroys thyroid cells and reduces the
mass of functioning thyroid tissue to below
a critical level
I - radioactive therapy I - diagnostic
studies
131
123
Therapeutic purposes:
I 300-600MBq orally
Maintenance dose of L-thyroxine 0.1mg daily
Diagnostic purposes:
I given on empty stomach orally on previous day of diagnosis
Dose: 5 micro curie
131
123
Indications:
Primary thyrotoxicosis
Autonomous toxic nodule
Follicular carcinoma of thyroid
Ectopic thyroid
Retrosternal thyroid
Contraindications:
Pregnancy and lactation
Children
Females desiring to have
pregnancy within a year
Advantages:
No surgery
No prolonged medical therapy
Disadvantages:
Hypothyroidism
Ophthalmopathy and Dermopathy - worsened
Effects will be seen only after 3 months
Induce hyperparathyroidism
Special conditions:
Pregnancy:
Radioiodine - absolutely contraindicated
Surgery – miscarriage
Antithyroid – thyroid insufficiency
Children:
Radioiodine contraindicated
Surgery- increased risk of recurrence
because thyroid cells highly active after
thyroidectomy in young.
Thyrocardiac:
-seen in patient with severe cardiac
damage due wholly or partly to
hyperthyroidism
-middle aged or elderly
-secondary thyrotoxicosis
-hyperthyroidism not very severe
Treatment: Beta blockers, radioiodine with
antithyroid drugs
Proptosis of recent onset:
Termination of thyrotoxicosis by
thyroidectomy or radioiodine when
proptosis is recent onset – result in
malignant exophthalmos.
High titres of thyroid antibodies:
Indicates lymphatic infiltration of goitre i.e.
diffuse or focal thyroiditis.
Treatment: anti-thyroid drugs
If medical treatment fails surgery or radio-
iodine is contraindicated.
steroids - reduce pain and swelling
RECENT ADVANCES IN THYROTOXICOSIS
overview
Advances in diagnosis
Advances in surgery
- MITS
- MIVAT
- ROBOTIC
Summary
Diagnostic advances
Radioactive iodine and Tecnitium99 scan
Radioactive iodine(I123) Tecnitium99 (Tc99)
costly Cheap
Oral intake on empty stomach
IV injection
Half life is 13 hours Half life is 6 hours
Radioactive iodine scan
Tc99
Normal
Grave’s
MNG
Txadenoma
Thyroiditis
SURGICAL ADVANCES
Long neck scar makes patients uncomfortable in public/ cosmetic
Scar length reduced but still, cosmetically not acceptable
Minimally Invasive Thyroid Surgery (MITS)
First endoscopic thyroidectomy was done by HUSHER ET AL in 1997.Hüscher CS, Chiodini S, Napolitano C et al (1997) Endoscopic right thyroid lobectomy. Surg Endosc11(8):877
KANG ET AL started using Axillaryapproach for thyroidectomy
Kang J, Ikeda Y, Takami H, Sasaki Y et al (2000) Endoscopic neck surgery by the axillary approach. J Am Coll Surg 191(3):336–340
MICCOLI ET AL introduced MINIMALLY INVASIVE VIDEO ASSISTED THYROIDECTOMY (MIVAT)
Miccoli P, Berti P, Frustaci GL et al (2006) Video-assisted thyroidectomy: indications and results. Langenbecks Arch Surg 391(2):68–71
LOMBARDIE ET AL evaluated patients undergone (retrospective study of 1350 patients) MIVAT and CT and reported MIVAT had superiority over CT
Lombardi CP, Raffaelli M, Princi P et al (2005) Safety of video-assisted thyroidectomy versus conventional surgery. Head Neck 27(1):58–64
Axillary approach
Advantages:
• Reduced tissue trauma
• Short hospital stay
• Better cosmetic results
• Minimal postop pain
• Patient more comfortable
Disadvantages:
• Longer duration of surgery
• Costly
• Steep learning curve
• More than 1 surgeon required
Patient selection for MITS
INDICATIONS CONTRAINDICATIONS
Thyroid nodule size <35mm (benign) and <20mm (malignant)
Malignancy other than low risk Papillary carcinoma thyroid
Thyroid gland volume <30ml on USG Gland volume >30ml
No previous neck surgeries Associated enlarged lymph nodes
No H/o irradiation Extra thyroidal extension, substernalextension
No H/o thyroiditis Obese patient
TECHNIQUE ADV DISADV
MIVAT Small incisionReduced painShort postop
Less tissue traumaNo drains required
Only for small thyroid<30cc
Long duration of surgerySteep learning curve
MIT Small incisionBetter cosmetic scar
Long duration of surgery
What more to come in
future????
Thyroid surgery through transoral route
Robotic thyroid surgery
Robotic thyroid surgery
• da Vinci system
• Computer motion system
• Zeus robotic system
Advantage Disadvantage
Spectacular view of surgical viewStable and accurate movement
Still evolving
Facilitates multiplanar dissection Cost of instillation of the system and maintanence
Proper exposure of primary site without constant retraction for
better visualisation
Lack of training of young surgeons
Better tissue dissection as the tip if the endoscope is in close vicinity to
the tissue
Summary
Use of radioactive iodine/Tc99 for diagnosis alongwith conventional diagnostic techniques
Use of new surgical technique like MIT/MIVAT over conventional thyroidectomy
Use of robotic surgery
Future holds more!!!!
Thank you
SURJEET ACHARYA